؉ . Moreover, the expression levels of cyclin D and E2F-1 induced by this parkinsonian neurotoxin were also attenuated by vit E. Since, the broad-spectrum caspase inhibitor zVAD-fmk did not attenuate MPP ؉ -induced apoptosis in CGNs, our data provide a caspase-independent mechanism mediated by neuronal reentry in the cell cycle and increased expression of the pro-apoptotic transcription factor E2F-1. Our results also suggest a potential role of oxidative stress in neuronal reentry in the cell cycle mediated by MPP ؉ . Finally, our data further support the therapeutic potential of flavopiridol, for the treatment of Parkinson's disease.
Parkinson's disease (PD), along with Alzheimer's disease, is probably the most common neurodegenerative disorders affecting the human population in old age (Moore et al., 2005; Cookson, 2005) . Several neurotoxins have been used to reproduce the disease and to study the potential mechanisms involved in PD. Thus, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a neurotoxin widely used in experimental neuroscience as a Parkinson's model in laboratory animals (Tretter et al., 2004; Crocker et al., 2003; Chee et al., 2005) . Once administered MPTP is converted by glial cells into 1-methyl-4-phenylpyridinium (MPP ϩ ), an inhibitor of the complex I mitochondrial respiratory chain that is responsible for neuronal toxicity (Gonzalez-Polo et al., 2004a) . Therefore, the main pathway proposed to explain the mechanism involved in PD centers upon mitochondrial alteration, oxidative stress generation, and apoptosis probably caused by caspase-3 activation (Chee et al., 2005; Beal, 2004; Gonzalez-Polo et al., 2004a; Choi et al., 2001; Dodel et al., 1999; Du et al., 1997) .
Furthermore, the hypothesis of reactive oxygen species (ROS) production is supported by in vitro studies showing that such antioxidants as vitamin E (vit E), coenzyme Q 10 , and other compounds with scavenger properties exert neuroprotective properties in neuronal cell cultures (Gonzalez-Polo et al., 2004a; Beal 2004) . Likewise, Gonzalez-Polo et al. (2001 , 2003a ,b, 2004a recently demonstrated that cerebellar granule neurons (CGNs) undergoing MPP ϩ treatment could induce apoptosis through mitochondrial alteration, caspase-3, activation and ROS generation. The same authors suggested that caspase activation, specifically of caspase-3, constitutes the last step and is the effector of this process. The role of caspase activation in MPP ϩ has been supported by other studies showing that caspase inhibitors offer robust neuroprotection (Gonzalez-Polo et al., 2004a) .
However, others authors have suggested that additional cysteine proteases could contribute to the apoptotic process mediated by complex I inhibition (Leist et al., 1998) . Among them are previous studies indicating that calpains, which are cysteine proteases activated by calcium, may be involved in the apoptotic process mediated by complex I inhibition in neuronal cell preparations. Moreover, Crocker et al. (2003) , in an excellent study adminis-tering calpain inhibitors in a mice model of PD, demonstrated the beneficial neuroprotective and behavioral effects of calpain inhibitors.
In an attempt to characterize the neuronal apoptotic mechanisms mediated by mitochondrial respiratory chain complex I inhibition, a caspase independent pathway has been recently suggested. Under this hypothesis MPP ϩ induces a release of the apoptosis-inducing factor (AIF), which is regulated by calpain activation (Chu et al., 2005; Liou et al., 2005) . Thus, these studies may explain why caspase inhibitors do not completely attenuate the apoptotic process mediated by inhibition of the mitochondrial complex I.
In the present study, therefore, we attempted to investigate the possible role of caspase-dependent and -independent routes in MPP ϩ -induced apoptosis in CGNs. In addition to the role cysteine proteases play in the apoptotic route orchestrated by MPP ϩ , recent studies suggest the potential role of cell cycle activation in neuronal apoptosis Raina et al., 2004; Bowser and Smith, 2002; Giovanni et al., 1999; Copani et al., 2001a Copani et al., ,b, 2002a . The hypothesis regarding the role of cell cycle reentry as a potential mechanism involved in neuronal cell death is based on studies performed in brains of Alzheimer's disease and PD patients where there is an increase in the expression of proteins involved in the cell cycle (Yang et al., 2001 (Yang et al., , 2003 Jordan-Sciutto et al., 2003) . Subsequent studies performed in neuronal cell preparations using different neurotoxins such as kainic acid (an agonist of non-NMDA receptors), camptothecin (a DNA damaging agent), and ␤-amyloid (an in vitro model of AD), suggest that re-expression of cell cycle proteins could constitute a common pathway involved in the mechanisms underlying neuronal cell death (Giovanni et al., 1999; Copani et al., 2001a; Verdaguer et al., 2004) . Although the exact mechanism by which neuronal reentry in the cell cycle induces apoptosis is not completely known, several studies suggest that the transcription factor E2F-1 could be the link Hou et al., 2000; Raina et al., 2001; Klein et al., 2002; Biswas et al., 2005; La Thangue, 2003, 2004) . Another interesting point lending support to the potential role of cell cycle reentry in neuronal apoptosis is that cyclin-dependent kinase inhibitors, mainly flavopiridol (FLAV), offer strong neuroprotective properties against several experimental apoptotic paradigms both "in vitro" and "in vivo" (Verdaguer et al., 2004; Di Giovanni et al., 2005; Cernak et al., 2005; Mirjany et al., 2002; Wu et al., 2004; Wang et al., 2002; Webber et al., 2005) . Since a characteristic common to all neurodegenerative diseases is the generation of oxidative stress production, one of the aims of the present study was to determine a relationship between oxidative stress production and reentry in the cell cycle (Herrup et al., 2004; Langley and Ratan, 2004; Becker and Bonni 2004) . To answer all of these questions in the present manuscript, we evaluated the neuroprotective effects of vit E and the broad-spectrum CDK inhibitor FLAV on MPP ϩ -induced apoptosis in CGNs. A study addressing the role of cell cycle reentry in the apoptotic route mediated by the parkinsonian neurotoxin MPP ϩ may be of potential interest to the development of pharmacological treatments for PD.
EXPERIMENTAL PROCEDURES Materials
Pharmacological agents used in this study include: MPP ϩ , rotenone, 3-methyladenine (3-MA), vit E, mimosine, roscovitine and propidium iodide (PI) from Sigma Chemical Co (St. Louis, MO, USA). zVAD-fmk was obtained from Bachem AG (Bubendorf, Switzerland), PD151746 from Calbiochem (Darmstadt, Germany), and cell culture media and fetal calf serum (FCS) from GIBCO (Life Technologies, Paisley, UK). FLAV was a gift from Aventis Inc.
Cell cultures salts, enzymes, Mowiol ® 4 -88 and Triton X-100 were purchased from Sigma (St. Louis, MO, USA). Other chemical reagents were of analytical quality and purchased from Sharlab (Barcelona, Spain) .
Cell cultures
Primary cultures of CGNs were prepared from postnatal day 7 Sprague-Dawley rat pups as described previously (Verdaguer et al., 2002) . Cells were dissociated in the presence of trypsin and DNase I and plated in poly-L-lysine (100 g/ml)-coated dishes at a density of 8ϫ10 5 cells/cm 2 in basal Eagle's medium supplemented with 10% heat-inactivated fetal bovine serum, 0.1 mg/ml gentamicin, 2 mM L-glutamine, and 25 mM KCl. Cytosine-D-arabinofuranoside (10 M) was added always to the culture medium 24 h after plating to prevent the replication of non-neuronal cells. The cultures were maintained at 37°C in a humidified incubator with 5% CO 2 , 95% air and left undisturbed until experiments were performed. All procedures involving animals and their care were approved by the ethics committee of the University of Barcelona, and were conducted in accordance with national (Generalitat de Catalunya) and international laws and policies (Guide for the Care and Use of Laboratory Animals, National Academy Press, Washington, DC, 1996) . All efforts were made to minimize the number of animals used and their suffering.
Treatment of CGNs and viability assays
CGNs were used after 7-10 days of in vitro culture. Drugs (FLAV, zVADfmk, 3-MA, PD151746) were added at the same time as MPP ϩ (200 M) to determine their effects. To assess the loss of cell viability, we used the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium] method. MTT was added to the cells at a final concentration of 250 M and incubated for 1 h, allowing the reduction in MTT to produce a dark blue formazan product. Media were then removed, and cells were dissolved in dimethylsulfoxide. Formazan production was measured by the absorbency change at 595 nm using a microplate reader (BioRad Laboratories, Richmond, CA, USA). Viability results were expressed as percentages. The absorbency measured from non-treated cells was taken to be 100%.
Analysis of apoptosis by flow cytometry
Apoptosis was measured upon 48 h of MPP ϩ treatment. Briefly, culture medium was removed, with the cells then collected from culture plates by pipetting and washing with PBS. Flow cytometer experiments were carried out using an Epics XL flow cytometer with PI (10 g/ml) added 30 min beforehand. The instrument was set up in the standard configuration: excitation of the sample was conducted using a 488 nm air-cooled argon-ion laser at 15 mW power as a standard. Forward scatter (FSC), side scatter (SSC), and PI red (620 nm) fluorescence values were then acquired. 
Detection of apoptotic nuclei by PI staining
PI staining was used to detect morphological evidence of apoptosis. CGNs were grown on glass coverslips following MPP ϩ treatment alone, or in the presence of neuroprotective drugs. Subsequently, cells were fixed in 4% paraformaldehyde/phosphate-buffered saline solution (PBS) pH 7.4 for 1 h at room temperature. After washing with PBS, cells were incubated for 3 min with a solution of PI in PBS (10 g/ml). Coverslips were mounted in Mowiol ® 4 -88. Stained cells were visualized under UV illumination using the 20ϫ objective and their digitized images then captured.
Treatment of apoptotic cells resulted in shrunken, brightly fluorescent, apoptotic nuclei exhibiting high fluorescence and condensed chromatin compared with non-apoptotic cells. Apoptotic cells were scored by counting at least 500 cells in each sample over three separate experiments.
Measurements of ROS
Levels of intracellular ROS were measured using the fluorescent probe 2,7-dichlorodihydrofluorescein diacetate (H 2 DCFDA). Briefly, cells were incubated for 30 min at 37°C in the presence of 10 M H 2 DCFDA (added from a 20 mM stock solution in dimethyl sulfoxide). H 2 DCFDA diffuses across the neuronal membranes, where acetates migrate by intracellular esterases. Oxidation of H 2 DCFDA occurs almost exclusively in the cytosol, and generates a fluorescent response that is proportional to ROS generation. After loading with the dye, neurons were washed in a Locke's buffer and fluorescence was measured at excitation wavelength of 488 nm and an emission wavelength of 510 nm in a Perkin-Elmer Victor 3 fluorimeter.
Immunodetection: Western-blot and immunocytochemistry analysis
Aliquots of cell homogenate, containing 30 g (cyclin E, cyclin D, cdk2, cdk4, PCNA, E2F-1 ␣-tubulin) or 5 g (␣-spectrin) of protein per sample, were analyzed by Western blot. Briefly, samples were placed in sample buffer (0.5 M Tris-HCl pH 6.8, 10% glycerol, 2% (w/v) SDS, 5% (v/v) 2-␤-mercaptoethanol, 0.05% Bromophenol Blue) and denatured by boiling at 95-100°C for 5 min. Samples were then separated by electrophoresis on 10% acrylamide gels, with proteins subsequently transferred to polyvinylidene fluoride (PVDF) sheets (ImmobilonTM-P, Millipore Corporation, Bedford, MA, USA) using a transblot apparatus (BioRad). Membranes were blocked overnight with 5% non-fat milk dissolved in TBS-T buffer (Tris 50 mM; NaCl 1.5%; Tween 20, 0.05%, pH 7.5). They were then incubated with primary monoclonal antibodies against ␣-spectrin, cyclin D, cyclin E, cdk4, cdk2, PCNA, E2F-1 and ␣-tubulin (1:1000, Santa Cruz Biotechnology, Santa Cruz, CA, USA). After 90 min, blots were washed thoroughly in TBS-T buffer and incubated for 1 h with a peroxidase-conjugated IgG antibody (Amersham Corporation, Arlington Heights, IL, USA). Immunoreactive protein was visualized using a chemiluminescence-based detection kit following the manufacturer's instructions (ECL kit; Amersham Corporation). Digital images were taken with a Chemidoc XRS (BioRad), which permits semi-quantitation of band intensity. Protein load was periodically monitored by Phenol Red staining the blot membrane or via immunodetection of ␤-tubulin.
For immunocytochemistry experiments, CGNs were grown on sterile coverslips. After stimuli, cells were washed twice in PBS and fixed in 4% paraformaldehyde/PBS, pH 7.4 for 1 h at room temperature. They were pre-incubated for 30 min in PBS containing 0.3% Triton X-100 and 30% normal horse serum at room temperature. The cultures were immunostained with antibodies specifics against cyclin D, cyclin E, cdk4, cdk2, PCNA and E2F-1 followed by rhodamine-conjugated anti-rabbit IgG or anti-mouse IgG (1:200). Subsequently, coverslips were thoroughly washed and mounted in Mowiol ® 4 -88, and cells were then imaged using fluorescence microscopy with a 100ϫ oil immersion objective (Nikon Eclipse).
Measurement of caspase activity
Caspase-3 activity was determined by using the colorimetric substrate Ac-DEVD-p-nitroaniline, a synthetic substrate of caspase-3. Briefly, cells were collected from each treatment by scraping and then lysed on ice in cell lysis buffer (50 mM Hepes, 100 mM NaCl, 0.1% CHAPS, 0.1 mM EDTA, pH 7.4) for 30 min. Cell homogenates (50 g) were then incubated with 200 M of colorimetric substrate in assay buffer (50 mM Hepes, 100 mM NaCl, 0.1% CHAPS, 10 mM dithiothreitol, 0.1 mM EDTA, pH 7.4) in 96-well plates at 37°C for 24 h. Absorbance of the cleaved product was measured at 405 nm using a microplate reader (BioRad). Results were expressed as the relative enzymatic activity per microgram of protein.
Statistical analysis
Data are given as the meanϮS.E.M. of at least four experiments involving four to six independent cultures. In all experiments, data were analyzed by ANOVA followed by post hoc Turkey-Kramer multiple comparisons tests. P-values lower that 0.05 were considered significant.
RESULTS

Neurotoxic effects of MPP ؉ in CGNs
We first established the suitable experimental conditions for characterizing the neurotoxic effects of the specific mitochondrial complex I inhibitor MPP ϩ in CGNs. This compound therefore was added to the culture medium (concentration range 1 M to 1 mM) after 8 days in vitro (DIV) over 24 -48 h. Cell viability was assessed by the MTT method (Fig. 1A) . Our results indicated that MPP ϩ induced a significant decrease in neuronal cell viability at 24 and 48 h, the percentage of neuronal survival after 24 h was 65Ϯ3 at 200 M and 50Ϯ3 at 500 M, the percentage of neuronal survival decreased 48 h (40Ϯ2 at 200 M and 31Ϯ3 at 500 M). Interestingly, neurons exposed to MPP ϩ doses of 200 M and higher had shrunken cell bodies with condensed nuclei, while untreated cells exhibited soma and abundant arborization of dendrites.
On the other hand, in agreement with previous studies, we observed a significant increase in ROS levels induced by MPP ϩ 200 M as assessed by the oxidation-sensitive fluorescent probe 2=-7=-dichlorofluorescein diacetate (DCFH-DA) (Gonzalez-Polo et al., 2003b , 2004b (Fig. 1C) .
Role of cysteine proteases, 3-MA and MK-801 in MPP ؉ -induced apoptosis
In an initial attempt to characterize apoptotic activation, we evaluated DNA fragmentation after treatment with MPP ϩ . Apoptosis is associated with lower DNA fluorescence in flow cytometric analysis, which is considered a useful tool for its quantitative detection. We found a significant increase in percentages of apoptotic cells (hypodiploid DNA content) at 24 and 48 h. The percentages of hypodiploid cells evaluated at 24 h were 10.7Ϯ1 in untreated CGNs. while an increase was measured up to 27.1Ϯ4 at 200 M, 30Ϯ4 at 500 M, and finally 32.8Ϯ4 1 mM (Fig. 1B, open  bars) . The percentage of apoptotic cells increased at 48 h with values of 40Ϯ3 at 200 M, 53Ϯ8 at 500 M, and 58Ϯ6 at 1 mM. We also determined the nuclear condensed nuclei at 200 M and 500 M after 48 h of treatment, finding a significant increase after neurotoxin treatment (Fig. 1B, filled bars) .
Given the contradictory results in the literature regarding the role of cysteine proteases in MPP ϩ -induced apoptosis, we investigated the role of caspase-3 activity and calpain in CGNs following treatment with 200 M MPP ϩ . Our results indicated that MPP ϩ 200 M was able to induce a slight increase in caspase-3 activation (about 35%). The relevance of caspase activation in the execution phase of MPP ϩ -induced cell death was evaluated by using zVAD-fmk, a broad range peptide inhibitor of caspases. Pretreatment of CGNs with 100 M zVADfmk prevented neither cell death (percentage of neuronal survival 42Ϯ3% nϭ5) nor apoptosis (percentage of hypodiploid cells 40Ϯ2% nϭ6 and condensed nuclei 50Ϯ4% nϭ3), suggesting that while caspase-3 may be activated, others pathways are responsible for the apoptotic process. Likewise, these data are consistent with other studies implicating a caspase-independent mechanism in MPP ϩ -induced apoptosis in CGNs (Chu et al., 2005) . We next investigated the activation of calpains using ␣-spectrin (fodrin) (240 kDa), a substrate of both calpains and caspases. In agreement with previous studies, treatment of CGNs with MPP ϩ induced calpain activation. Thus, our results indicate distinct increases in the 150 kDa and 145 kDa bands at 12, 24, and 48 h of MPP ϩ 200 M treatment (Fig. 2) . In addition, caspase activation leads to a slight increase in 120 kDa bands (specific for caspase-3), in accordance with previous results. To elucidate whether calpain activation is responsible for mitochondrial complex I inhibition-induced apoptosis in CGNs, we used a specific inhibitor of calpains PD151746. Increasing concentrations (1-60 M) of calpain inhibitor in the medium did not correlate with increased cell viability, nor was apoptosis as measured by flow cytometry prevented with PD151746 treatment. Furthermore, this compound failed to decrease the number of condensed nuclei. Thus, our data indicate that although cysteine proteases are activated under our experimental conditions, the use of caspase and calpain inhibitors prevents neither cell death nor apoptosis (Fig. 2) .
Mitochondria are the regulators of an apoptotic process that induces the release of proteins orchestrating the activation of either a caspase-dependent or -independent pathway (Gonzalez-Polo et al., 2004a) . Our Western-blot results indicate that MPP ϩ treatment of CGNs induces a release of AIF from mitochondria to the cytoplasm, suggesting that a caspase-independent process is involved in MPP ϩ -induced apoptosis (Fig. 4) . Then, we have investigated the implication of autophagia in our cell system. To this end, we tested the neuroprotective effects of the autophagy inhibitor 3-MA. Our results indicate that 3-MA (concentration range 1-10 mM) failed to afford any neuroprotective effects. In addition, 3-MA 5 mM prevented neither DNA fragmentation nor nuclear condensation (Fig. 2) . Because CGNs express NMDA receptors and the neurotoxic effects of MPP ϩ could be mediated by an interaction with these glutamate receptors, we decided to test the effects of MK801, a selective NMDA receptor antagonist in our experimental conditions (Finiels-Marlier et al., 1993) . Our results indicate that this selective compound did not prevent MPP ϩ -induced DNA fragmentation in CGNs (Fig. 3) .
MPP
؉ induces the expression of cell cycle proteins
Since under our experimental conditions neither of the cysteine protease inhibitors zVADfmk and PD 151746 produced any antiapoptotic effects we tested the hypothesis that a caspase-independent apoptotic mechanism modulated by ROS may be involved in MPP ϩ -induced apoptosis in CGNs. Like previous studies suggesting a direct role for oxidative stress and cell cycle activation, we were interested in determining whether treatment of CGNs with MPP ϩ could induce the expression of cell cycle proteins (Klein et al., 2002; Langley and Ratan, 2004) . Semi-quantitative Western blot analysis demonstrated a significant increase in the expression of cyclin D, cyclin E, cdk2 and cdk4 at 12 and 24 h after treatment with 200 M MPP ϩ (Fig. 4) . The immunocytochemical data indicate that these proteins showed both a nuclear and cytoplasmic localization (Fig. 8) . The increased expression of E2F-1 was also evaluated since previous studies support the role of this transcription factor in neuronal apoptosis. Data indicated a significant increase in E2F-1 expression as measured by Western blot analysis (Fig. 4) . Furthermore, our immunocytochemical data showed a nuclear and cytoplasmic localization of E2F-1 (Fig. 8) .
The proliferating control nuclear antigen (PCNA) has been implicated in the machinery of the DNA replication complex, which is regulated by the activation of S-phaserelated CDKs. An antibody against PCNA showed a robust increase in CGNs after MPP ϩ treatment. Further immunoblotting analysis confirmed the upregulation of PCNA (Fig. 4) .
We also evaluated the effects of rotenone, an inhibitor of mitochondrial complex I in order to confirm that the increase in E2F-1 expression may be an apoptotic route induced by these mitochondrial toxins. First, we determined changes in cell viability and DNA fragmentation in response to different dosages of rotenone (Fig. 5) . Furthermore, we fixed the concentration at 200 nM and we treated CGNs during 24 h to evaluate the expression of E2F-1 by Western blot. As indicate in Fig. 5 , panel B, there was a significant increase in E2F-1 expression after rotenone treatment.
Neuroprotective and antiapoptotic roles of FLAV
Since we demonstrated an increase in the expression of CDKs after MPP ϩ treatment of CGNs, we examined the neuroprotective role of FLAV, a broad-spectrum CDK inhibitor with potential anti-tumoral applications. CGNs were pretreated with FLAV (0.1, 0.5, 1 or 5 M) and with 200 M MPP ϩ . Our data show that FLAV significantly protected CGNs from MPP ϩ (MTT values from 38Ϯ1.8% to 70Ϯ5% in presence of FLAV 5 M) (Fig. 6B ). This increase in MTT values correlates with the higher numbers of viable neurons at 48 h as assessed by phase-contrast microscopy (Fig. 6A) . Indeed, the addition of FLAV to the culture medium clearly diminished the percentage of the hypodiploid population, changes that were significant when compared with MPP ϩ (control 10%; MPP ϩ 40%Ϯ3; and FLAV 5 M 15%Ϯ3) (Fig. 4B) . After MPP ϩ treatment with we found a significant increase in the number of condensed nuclei (8.5%Ϯ0.6 control; 53.6Ϯ1.7 MPP ϩ -treated cells). Cell condensation also decreased significantly when CGNs were treated with different concentrations of FLAV (20Ϯ3.3%, 0.1 M; 12.2Ϯ2.2, 0.5 M; 12.6Ϯ1.9 1 M and 11.5Ϯ1.5 5 M) (Fig. 4B) . Finally, FLAV attenuates the expression of the proapoptotic factors cyclin D and E2F-1 and cell cycle proteins (Fig.  8A-B) . On the other hand, we demonstrated that FLAV (1 M) decrease ROS production mediated by MPP ϩ 200 M (Fig. 7C ).
Neuroprotective effects of Vit E on MPP ؉ -induced apoptosis in CGNs
To explore the potential implication of ROS in the cell cycle reentry mediated by MPP ϩ , we evaluated the neuroprotective effects of vit E. Based on a MTT assay, vit E protects against MPP ϩ neurotoxicity in a concentrationdependent manner (Fig. 7B) . Furthermore, changes in cell morphology were assessed by microscopic examination, revealing that vit E pretreatment mitigated the morphological features of damaged cells (Fig. 7A) . With regard to antioxidant treatment (Fig. 7A-B) . Indeed, vit E 15 M prevented MPP ϩ -induced ROS production (Fig. 7C) . To clarify the potential implication of oxidative stress in MPP ϩ -induced expression of cell cycle proteins, we evaluated their expression in the presence of vit E 15 M. After treatment with MPP ϩ , vit E attenuated the expression of E2F-1 a transcription factor involved in neuronal apoptosis and cylin D (Fig. 8B) .
Role of mimosine and roscovitine in MPP ؉ -induced apoptosis in CGNs
In order to evaluate the role of cell cycle in complex I inhibition-induced apoptosis, we study the effects of two compounds mimosine and roscovitine. It is well known that mimosine is a naturally occurring plant amino acid that arrests the cell cycle in the late G1 phase, however its mechanism of action is not completely known (Copani et al., 2001b) . Roscovitine is a more selective cdk1, cdk2 and cdk5 inhibitor (Frade, 2000) . Our data clearly indicate that mimosine (1-100 M) prevents apoptosis DNA fragmentation measured by flow cytometry and nuclear condensation. On the other hand, roscovitine at the concentrations used in the present study did not showed any significant antiapoptotic effects against MPP ϩ treatment (Fig. 9) .
DISCUSSION
In the present study, we demonstrate several interesting points: at first, in agreement with recent data from others authors, we suggest a caspase-independent mechanism of neuronal cell death mediated by the complex I inhibitor MPP ϩ (Chu et al., 2005; Liou et al., 2005) . Secondly, we demonstrate that complex I inhibition induced the release of AIF, whose caspase-independent role in apoptosis is well-known. Thirdly, our data show that MPP ϩ not only induces a distinct increase in the expression of cell cycle proteins, but also induces an increase in the expression of E2F-1, a transcriptional factor involved in neuronal apoptosis (Giovanni et al., 1999; Copani et al., 2002b; Hou et al., 2000) . These data were corroborated using rotenone a neurotoxin which also inhibits the mitochondrial complex I. Finally, we show that FLAV, a broad inhibitor of CDKs, offers neuroprotective properties against MPP ϩ -induced apoptosis. The data presented here demonstrate that MPP ϩ -induced apoptotic cell death can be inhibited by several agents that interact with cell cycle regulatory mechanisms. These include inhibitors of CDKs as well as agents that block the G1/S transition, i.e. mimosine. Therefore, this study indicates that the signals that trigger apoptosis in response to MPP ϩ involve cell cycle signals. Likewise, G1/S checkpoint is important in controlling apoptosis in neurons. Furthermore, we propose that oxidative stress could be the link between mitochondrial complex I alteration and reentry in the cell cycle. This last hypothesis is supported by the fact that vit E showed neuroprotective properties in this experimental model of PD, preventing the expression of several proteins involved in cell cycle regulation.
When we characterized the neurotoxicity of MPP ϩ under our experimental conditions, we detected the signs of apoptosis (nuclear condensation and DNA fragmentation) and a major decrease in cell viability at 48 h, in agreement with Shang et al. (2003 Shang et al. ( , 2004 . For this reason, we decided to evaluate the neuroprotective effects of cysteine protease inhibitors and other drugs after 48 h of MPP ϩ treatment. Controversial data surround the apoptotic pathways involved in mitochondrial complex I inhibition by MPP ϩ . Meanwhile, several authors have suggested a role for caspase-3, while others have postulated a caspase-independent mechanism (Gonzalez-Polo et al., 2004a; Chu et al., 2005; Liou et al., 2005) . Therefore, although we detected slight caspase-3 activation, under these experimental conditions, our results suggest that this cysteine protease is not critical for MPP ϩ -induced apoptosis. Furthermore, our hypothesis is supported by the fact that the broad-spectrum inhibitor zVAD-fmk attenuated neither cell viability nor apoptosis mediated by MPP ϩ . These results are in agreement with the idea that caspase inhibitors do more than prevent apoptosis, attenuate it, or delay the process, but do not offer strong neuroprotection (Leist et al., 1998) . For instance, in the model of colchicine-induced apoptosis in CGNs in the presence of caspase inhibitors (for example zVAD-fmk) apoptosis occurs at 48 h of treatment (Volbracht et al., 2001) . Therefore, we propose that MPP ϩ -induced apoptosis under our experimental conditions is a caspase-independent process.
Furthermore, we demonstrated that MK-801, a selective NMDA antagonist of glutamate ionotropic receptors did not prevents apoptosis mediated by the neurotoxin MPP ϩ (Dipasquale et al., 1991; Marini and Paul, 1992) . So, these results suggest that in our experimental conditions NMDA receptor does not play a major role in MPP ϩ -induced apoptosis.
Since previous studies implicate the activation of calpains in a mice model of PD (Leist et al., 1998; , we also evaluated the neuroprotective role of PD151746, a cell permeable calpain I and II inhibitor, in MPP ϩ -induced apoptosis. Although our data suggest calpain activation, as measured by the formation of the specific 145 kDa fragment from ␣-spectrin breakdown, the calpain inhibitor PD151746 failed to protect against MPP ϩ neurotoxicity. Although previous studies suggest that calpain inhibitors attenuate neurotoxicity mediated by MPP ϩ (Leist et al., 1998) , the discrepancies between these results and our own findings could be explained by the different MPP ϩ concentrations employed (50 M vs. the 200 M we use), as well as by the different culture exposure times (4 h vs. the 48 h we employed). Thus, the experimental conditions, drug concentrations and treatment times, could favor a caspase-dependent or -independent apoptotic process. On the other hand, we did not find any neuroprotective effects with the autophagy inhibitor 3-MA (Lang-Rollin et al., 2003; Stefanis, 2005) . However, this result does not mean that autophagia, which is implied by lysosomes and activation cathepsin, is not activated in MPP ϩ -induced apoptosis, as we do not use specific markers of autophagia. Our results allow us to propose that inhibition of autophagia is not a key component of the apoptotic route implicated in MPP ϩ induces apoptosis in CGNs.
In agreement with previous articles, our results demonstrate that MPP ϩ increases not only oxidative stress generation, but also the release of AIF from mitochondria (Chu et al., 2005) . Using Western blot analysis, we determined the mitochondrial release to the cytoplasm of AIF mainly for two reasons: AIF is involved in neuronal apoptosis independently of caspase activation, and furthermore, AIF is a flavoprotein that has demonstrated an antioxidant effects under physiological conditions (Klein et al., 2002) . Our data are in line with recent studies which suggest a caspase-independent mechanism activated after the inhibition of mitochondrial complex I (Chu et al., 2005; Liou et al., 2005) . Nonetheless, Liou et al. (2005) demonstrated in PC12 cells that following treatment with MPP ϩ in the presence of calpain inhibitors, only partial neuroprotective effect results. These neuroprotective effects of calpain inhibitors were attributed to the inhibition of AIF release, since recent studies demonstrated that calpain I mediated this release from mitochondria (Polster et al., 2005) . Likewise, Chu et al. (2005) showed a partial protection against MPP ϩ by reducing AIF expression by siRNA knockdown. Taking into account all these data, AIF could play an intermediate role in caspase-independent apoptosis mediated by MPP ϩ . The proposed antioxidant mechanism of AIF could occur either through the recycling of glutathione or by a coupling with the antioxidant functions of the glutaredoxin system (Klein et al., 2002) . Therefore, it is possible to speculate the mitochondrial release of AIF mediated by MPP ϩ may favor neuronal oxidative stress and DNA damage, which in turn that could favor cell cycle reentry.
To clarify the role of ROS and reentry in the cell cycle, we used vit E a potent inhibitor of ROS production that affords neuroprotective properties in several paradigms of neurotoxicity. In this context, our data indicate that vit E and FLAV attenuate MPP ϩ -induced ROS production. Moreover, we found a significant decrease in the expression of E2F-1. These results, in agreement with previous studies (Gonzalez-Polo et al., 2003b) , not only demonstrate the importance of ROS in the apoptotic route of the neurotoxin MPP ϩ , but also indicate a link between oxidative stress and reentry in the cell cycle (Langley and Ratan, 2004) . However, it is still unknown whether oxidative-stress-induced neuronal apoptosis requires cell cycle expression or if more than DNA synthesis reentry in the cell cycle constitutes an alternative pathway for DNA repair (Langley and Ratan, 2004) .
Previous studies demonstrated the expression of cell cycle regulators in brain samples of patients with PD . Additionally, increasing evidence suggests that the increased expression of proteins regulating the cell cycle is associated with cases of Alzheimer's disease (Arendt, 2002; Casadesus et al., 2005; Herrup and Arendt, 2002; Herrup et al., 2004; Busser et al., 1998; Jordan-Sciutto et al., 2002 ), Pick's disease (Nagy et al., 1997) , progressive supranuclear palsy (Nagy et al., 1997) , corticobasal degeneration (Nagy et al., 1997) , amyotrophic lateral sclerosis (Ranganathan and Bowser, 2003; Nguyen and Julián, 2003) and Down syndrome (Motonaga et al., 2001) . Likewise, recent studies give support to the importance of CDKs in PD, specifically in dopaminergic dysfunction . Furthermore, there has been report of the cell-cycle CDKs substrate pRb in postmortem PD brain samples, suggesting that cdk2, might be activated in this disease . Therefore, aberrant activation of cell cycle progression is a promising hypothesis underlying neuronal apoptosis, and may constitute a potential pharmacological target (Pallàs et al., 2005) . So, it is possible to suggest that reentry into the cell cycle might be a common component of the process of neuronal cell death. However, neurons are terminally differentiated and postmitotic, having exited the cell cycle irreversibly. Thus, an increase in the expression of cell cycle proteins may cause unfavorable effects on neurons, specifically inducing the expression of the proapoptotic transcriptional factor E2F-1 (Hou et al., 2001; R.A. Smith et al., 2003) . In agreement with this hypothesis, we demonstrated in the present study that vit E and FLAV attenuated the increased expression of the transcription factor E2F-1 mediated by MPP ϩ . Roscovitine failed to prevent MPP ϩ -mediated apoptosis. This result suggests that cdk2 and cdk1 are not critical for the apoptotic effects of MPP ϩ and these data are consistent with others reports which demonstrated that roscovitine depending on the apoptotic stimuli increases the neuronal toxicity or does not showed any neuroprotective effects (Frade, 2000; Maas et al., 1998; R.A. Smith et al., 2003) .
Our results could also help to unify the hypothesis regarding the mechanisms of neuronal cell death. In this context a "two-hit hypothesis" has been proposed for Alzheimer's disease wherein cell cycle reentry and ROS are the two main components necessary for the development of Alzheimer's disease . In the present manuscript, therefore, both our and previous data are in agreement that ROS are generated after treatment with MPP ϩ . Moreover, we have here identified the appearance of the second "hit" reentry in the cell cycle.
Our results are in line with previous studies where FLAV protects against excitotoxicity (Mirjany et al., 2002 ), brain trauma and ␤-amyloid treatment (Copani et al., 2001a) and offers neuroprotection against this experimental model of Parkinson disease (R.A. . Thus, taking into account all these neuroprotective data with this drug and others CDK inhibitors' reentry in the cell cycle is more than a consequence of apoptosis and could be a cause of apoptosis (Kruman, 2004) .
Interesting is the potential therapeutic use of FLAV in the treatment of neurodegenerative diseases. FLAV is an antitumoral drug that is in phase II in clinical trials for cancer treatment (Shapiro, 2004) . The neuroprotective effects of FLAV may be explained by the inhibition of CDKs implicated in cell cycle proliferation, thus preventing increased expression of E2F-1 (Phillips and Vousden, 2001 ). Other mechanisms involved in the neuroprotective properties of FLAV may be the inhibition of CDK5 and GSK-3␤ activity (Pallàs et al., 2005) . Although this drug may have some undesirable side effects due to its antitumoral activity, according to the "two-hit hypothesis" the potential combination of an antioxidant (vit E) drug and a cell cycle inhibitor (FLAV) could be a potential treatment in the prevention of neurodegenerative processes.
